Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

BACKGROUND: We conducted a randomized controlled trial to investigate whether an additional platelet inhibition with tirofiban would reduce the extent of myocardial damage and prevent periprocedural myonecrosis in patients with Non-ST-elevation acute coronary syndrome (NSTE-ACS) with a high residual...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cardiovasc Disord
Auteurs principaux: Lee, Wonjae, Suh, Jung-Won, Park, Jin Joo, Yoon, Chang-Hwan, Cho, Young-Seok, Youn, Tae-Jin, Chae, In-Ho
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6198526/
https://ncbi.nlm.nih.gov/pubmed/30348101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0938-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires